Certolizumab treatment of localized pyoderma gangrenosum in a pregnant patient

CONCLUSION: Certolizumab may be a promising therapeutic option for patients with severe PG.PMID:37905433 | DOI:10.1080/09546634.2023.2276044

Source: Journal of Dermatological Treatment - October 31, 2023 Category: Dermatology Authors: Na Wang Changping Yu Weiwei Wang Qing Yang Source Type: research